LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Search

Avita Therapeutics Inc

Avatud

10.12 -2.22

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.1

Max

10.56

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+109.77 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. nov 2024

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Avita Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. okt 2024, 23:02 UTC

Peamised uudised

Australian Consumer-Confidence Recovery Still Intact Amid Building Rate-Cut Hopes

28. okt 2024, 23:01 UTC

Suurimad hinnamuutused turgudel

Lithium Americas Shares Rise After News of DOE Loan

28. okt 2024, 22:40 UTC

Tulu

Correction to Bristol-Myers Squibb 2024 Guidance Headline on July 26

28. okt 2024, 22:29 UTC

Tulu

Waste Management Posts Revenue Growth on Price Increases

28. okt 2024, 23:52 UTC

Peamised uudised

McDonald's Finds an Unlikely Savior to Finally Fix Its McFlurry Machines -- Update

28. okt 2024, 23:42 UTC

Market Talk

Lithium Spodumene Prices Have Likely Bottomed -- Market Talk

28. okt 2024, 23:07 UTC

Peamised uudised

McDonald's Finds an Unlikely Savior to Finally Fix Its McFlurry Machines -- WSJ

28. okt 2024, 23:00 UTC

Tulu

WuXi AppTec 3Q Rev CNY10.46B, Down 2% on Year >603259.SH

28. okt 2024, 22:59 UTC

Tulu

WuXi AppTec 3Q Net CNY2.29B , Down 17% on Year >603259.SH

28. okt 2024, 22:15 UTC

Tulu

Sandfire Resources Net Debt $345 Million at End-Sept

28. okt 2024, 22:15 UTC

Tulu

Sandfire Resources 1Q Underlying Ebitda $121 Million

28. okt 2024, 22:15 UTC

Tulu

Sandfire Resources 1Q Unaudited Sales Revenue $282 Million

28. okt 2024, 22:14 UTC

Tulu

Sandfire Resources 1Q Underlying Operating Cost of $78/Ton of Ore Processed at Matsa Operation

28. okt 2024, 22:14 UTC

Tulu

Sandfire Resources 1Q Underlying Operating Cost of $40/Ton of Ore Processed at Motheo Operation

28. okt 2024, 22:13 UTC

Tulu

Sandfire Resources Says Copper Equivalent Output at Matsa Operation Up 4% in 1Q

28. okt 2024, 22:13 UTC

Tulu

Sandfire Resources Reaffirms FY 2025 Output, Cost, Capex Guidance

28. okt 2024, 22:12 UTC

Tulu

Sandfire Resources 1Q Silver Output 1.3 Million Oz, Up 9% on Quarter

28. okt 2024, 22:12 UTC

Tulu

Sandfire Resources 1Q Lead Output 2,081 Tons, Up 9% on Quarter

28. okt 2024, 22:12 UTC

Tulu

Sandfire Resources 1Q Zinc Output 21,542 Tons, Down 1% on Quarter

28. okt 2024, 22:11 UTC

Tulu

Sandfire Resources 1Q Copper Output 27,012 Tons, Down 1% on Quarter

28. okt 2024, 22:11 UTC

Tulu

Sandfire Resources 1Q Copper Equivalent Output 38,000 Tons, Flat on Quarter

28. okt 2024, 22:07 UTC

Tulu

China Southern Airlines: Strong Travel Demand Supported Results >1055.HK

28. okt 2024, 22:07 UTC

Tulu

China Southern Airlines 9-Mos Rev CNY134.66B Vs. CNY119.49B >1055.HK

28. okt 2024, 22:07 UTC

Tulu

China Southern Airlines 9-Mos Net CNY1.97B Vs. Net CNY1.32B >1055.HK

28. okt 2024, 22:01 UTC

Tulu

CMOC Group: Higher Income From Mining and Processing Segment Supported Results >3993.HK

28. okt 2024, 22:00 UTC

Tulu

CMOC Group 3Q Rev CNY51.94B, Up 15.5% on Year >3993.HK

28. okt 2024, 21:59 UTC

Tulu

CMOC Group 3Q Net CNY2.86B , Up 64.1% on Year >3993.HK

28. okt 2024, 21:38 UTC

Omandamised, ülevõtmised, äriostud

Fomento Economico Mexicano to Sell Plastics Solutions Operations to AMMI for MXN3.17B

28. okt 2024, 21:23 UTC

Tulu

Waste Management Raises 2024 Revenue View to Up 6% >WM

28. okt 2024, 21:21 UTC

Tulu

Waste Management 3Q Adj EPS $1.96 >WM

Võrdlus sarnastega

Hinnamuutus

Avita Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

109.77% tõus

12 kuu keskmine prognoos

Keskmine 21.25 USD  109.77%

Kõrge 40 USD

Madal 9 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Avita Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

4

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

10.41 / 10.705Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Finantsandmed

$